2009 Buick Lucerne CXL Special Edition
3.9 L • V6 • FWD • AT
1G4HD57M79U120974
Sales history: 2
• $200Highlights
Condition
Not provided
Seller
Unknown
Key included
Yes
Docs
Good
History
2 records
Drive
3.9 L • V6 • FWD • AT
Odometer
Not provided
Primary damage
Biohazard chemical
Secondary damage
Hail
Docs
TX • Cert Title
Extra
Auction
VIN
1G4HD57M79U120974
Lot number
91789975
Copart
Sale status
Sold
Location
Abilene, TX
Description
Fuel type
Gasoline
Body color
Silver
Body type
Sedan
Trim
CXL Special Edition
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Buick models
2009 Buick Lucerne CXL Special Edition • 3.9 L • V6 • FWD • Automatic • Copart Lot: 91789975 • VIN: 1G4HD57M79U120974
Find out more about this 2009 Buick Lucerne CXL Special Edition, available at the Copart salvage car auction as lot 91789975 in Abilene, TX. This car has Biohazard chemical main damage. It is listed with start condition code. Odometer shows Not provided. This Silver Buick Lucerne Sedan is equipped with Gasoline 3.9 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 1G4HD57M79U120974 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
